Selinexor, Bortezomib, and Dexamethasone for Heavily Pretreated Multiple Myeloma: A Case Series

被引：5
|
作者：
Magen, Hila [1 ,2 ]
Geva, Mika [1 ,2 ]
Volchik, Yulia [1 ]
Avigdor, Abraham [1 ,2 ]
Nagler, Arnon [1 ,2 ]
机构：
[1] Chaim Sheba Med Ctr, Div Hematol & Bone Marrow Transplantat, Dept Hematol, Ramat Gan, Israel
[2] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2020年 / 20卷 / 12期
关键词：
Heavily treated patients; Hematologic malignancies; Relapsing/refractory multiple myeloma; Selective inhibitor of nuclear export; Treatment response; TOPOISOMERASE-II; ORAL SELINEXOR; NUCLEAR EXPORT; INHIBITION; DIAGNOSIS; CRITERIA; CELLS;
D O I：
10.1016/j.clml.2020.07.016
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：E947 / E955
页数：9
相关论文
共 50 条
  • [1] Selinexor in combination with dexamethasone with or without bortezomib in heavily pretreated multiple myeloma: A case series
    Aung, Nini
    Bowers, Margaret
    Brearton, Gillian
    Charlton, Andrew
    Craig, Joanne
    Cullis, Jonathan
    Dang, Ray
    Donaldson, David
    Drake, Mary
    Hall, Rachel
    Parkins, Elizabeth
    Tighe, Jane
    Bygrave, Ceri
    Sheehy, Oonagh
    EJHAEM, 2024, 5 (05): : 987 - 991
  • [2] Selinexor, Bortezomib and Dexamethasone: An Effective Salvage Regimen for Heavily Pretreated Myeloma Patients
    Delforge, Michel
    Raddoux, Jolien
    Antonis, Corine
    Clement, Celine
    Kint, Nicolas
    Vanhellemont, Anneleen
    Bravetti, Julie
    Vandenberghe, Peter
    ONCOTARGETS AND THERAPY, 2022, 15 : 243 - 250
  • [3] Bendamustine-Bortezomib-Dexamethasone in Heavily Pretreated Multiple Myeloma
    Cerchione, Claudio
    Catalano, Lucio
    Nappi, Davide
    Pareto, Anna Emanuele
    Basile, Santina
    Marano, Luana
    Peluso, Ilaria
    Simeone, Luigia
    Vitagliano, Orsola
    Palmieri, Salvatore
    Rocco, Stefano
    Pane, Fabrizio
    Ferrara, Felicetto
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S254 - S255
  • [4] Selinexor, Bortezomib, and Dexamethasone (SVD) in Heavily Treated Relapsed Refractory Multiple Myeloma
    Mouhieddine, Tarek
    Parekh, Samir
    Cho, Hearn Jay
    Richter, Joshua
    DeCastro, Andrew
    Shah, Jatin
    Landesman, Yosef
    Chari, Ajai
    Jagannath, Sundar
    Madduri, Deepu
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S292 - S293
  • [5] Selinexor, bortezomib, and dexamethasone (SVD) in heavily treated relapsed refractory multiple myeloma
    Tarek H. Mouhieddine
    Samir Parekh
    Hearn Jay Cho
    Joshua Richter
    Andrew DeCastro
    Jatin Shah
    Yosef Landesman
    Ajai Chari
    Sundar Jagannath
    Deepu Madduri
    Annals of Hematology, 2021, 100 : 3057 - 3060
  • [6] Selinexor, bortezomib, and dexamethasone (SVD) in heavily treated relapsed refractory multiple myeloma
    Mouhieddine, Tarek H.
    Parekh, Samir
    Cho, Hearn Jay
    Richter, Joshua
    DeCastro, Andrew
    Shah, Jatin
    Landesman, Yosef
    Chari, Ajai
    Jagannath, Sundar
    Madduri, Deepu
    ANNALS OF HEMATOLOGY, 2021, 100 (12) : 3057 - 3060
  • [7] BENDAMUSTINE-BORTEZOMIB-DEXAMETHASONE (BVD) IN HEAVILY PRETREATED MULTIPLE MYELOMA
    Cerchione, C.
    Catalano, L.
    Nappi, D.
    Pareto, A. E.
    Basile, S.
    Marano, L.
    Peluso, I.
    Simeone, L.
    Vitagliano, O.
    Palmieri, S.
    Rocco, S.
    Ferrara, F.
    Pane, F.
    HAEMATOLOGICA, 2018, 103 : S86 - S86
  • [8] Lenalidomide (Revlimid), bortezomib (Velcade) and dexamethasone for heavily pretreated relapsed or refractory multiple myeloma
    Jimenez-Zepeda, Victor H.
    Reece, Donna E.
    Trudel, Suzanne
    Chen, Christine
    Tiedemann, Rodger
    Kukreti, Vishal
    LEUKEMIA & LYMPHOMA, 2013, 54 (03) : 555 - 560
  • [9] Selinexor–Bortezomib–Dexamethasone: A Review in Previously Treated Multiple Myeloma
    Yahiya Y. Syed
    Targeted Oncology, 2023, 18 : 303 - 310
  • [10] Lenalidomide (Revlimid), Bortezomib (Velcade) and Dexamethasone (RVD) for Heavily Pretreated Relapsed or Refractory Multiple Myeloma
    Jimenez-Zepeda, Victor H.
    Reece, Donna E.
    Trudel, Suzanne
    Chen, Christine
    Kukreti, Vishal
    BLOOD, 2011, 118 (21) : 1266 - 1267
12345